Summary & Overview
HCPCS G9933: Screening Colonoscopy with Adenoma or Colorectal Cancer Detected
HCPCS Level II code G9933 designates a screening colonoscopy in which adenoma(s) or colorectal cancer are detected. This distinction is important nationally because it separates a screening encounter from diagnostic or surveillance procedures when pathology is identified at the time of a screening exam, which can affect billing pathways, patient cost-sharing determinations, and quality reporting.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for G9933, payer coverage considerations, and what is typically documented on the service line for a screening colonoscopy that yields adenomatous polyps or malignancy. The publication outlines common modifiers associated with endoscopic services and summarizes how payers treat screening conversions to diagnostic care.
This report also provides benchmarks where available, highlights recent policy updates relevant to screening colonoscopy coding, and explains implications for revenue cycle workflows and medical record documentation. Data not available in the input will be clearly marked. The content is written for a national audience of clinicians, coding professionals, and revenue cycle managers seeking concise clarification of the use and significance of HCPCS Level II code G9933.
Billing Code Overview
HCPCS Level II code G9933 reports adenoma(s) or colorectal cancer detected during screening colonoscopy. The code represents a screening colonoscopy in which a clinician identifies adenomatous polyps or colorectal malignancy during a procedure initially performed for screening purposes.
Service type: Screening colonoscopy with detection of adenoma(s) or colorectal cancer
Typical site of service: Ambulatory surgery center or hospital outpatient department (endoscopy suite)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male undergoes a screening colonoscopy after a positive fecal immunochemical test (FIT). During the colonoscopic exam, the endoscopist identifies multiple adenomatous polyps in the sigmoid colon and a 2.5 cm lesion concerning for invasive colorectal cancer in the ascending colon. The procedure includes diagnostic inspection, polypectomy of the adenomas with snare removal and biopsy of the larger lesion. The patient is recovered in the endoscopy unit and scheduled for pathology review, oncology referral, and possible staging studies depending on pathology. Typical workflow steps: pre-procedure evaluation and informed consent, moderate sedation or monitored anesthesia care, colonoscopic inspection, therapeutic interventions (polypectomy, biopsy), specimen submission to pathology, recovery and discharge instructions, and coordination of follow-up care including surgical or oncology referral if malignancy confirmed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, time, or complexity substantially exceeds typical colonoscopy-related procedures (document justification). |
23 | Unusual anesthesia |